Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ION-717 by Ionis Pharmaceuticals for Neurodegenerative Diseases: Likelihood of Approval
ION-717 is under clinical development by Ionis Pharmaceuticals and currently in Phase II for Neurodegenerative Diseases. According to GlobalData, Phase...